AEMD Aethlon Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AEMD

Price (delayed)

$2.93

Market cap

$1.39M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$53

Enterprise value

-$3.4M

?
Relative Growth: Rel. Growth: 25
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 9

Aethlon Medical, Inc. is developing the Hemopurifier ®, an investigational extracorporeal therapeutic designed to remove tumor-derived extracellular vesicles and enveloped viruses from the bloodstream. The Company is advancing the Hemopurifier ...

Highlights
Aethlon Medical's EPS has surged by 88% YoY and by 80% QoQ
The company's debt fell by 48% YoY and by 19% QoQ
The quick ratio has contracted by 37% from the previous quarter but it has grown by 19% YoY
The company's equity fell by 27% QoQ and by 4.6% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.aethlonmedical.com
Peers: INO BRKR PACB COHR

Key stats

What are the main financial stats of AEMD

AEMD stock price

How has the Aethlon Medical stock price performed over time
Intraday
-3.62%
1 week
-2.98%
1 month
-12.54%
1 year
-95.24%
YTD
-78.84%
QTD
-28.88%

Financial performance

How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.29M
Net income
-$7.15M
Gross margin
N/A
Net margin
N/A
The net income has increased by 47% year-on-year and by 38% since the previous quarter
The company's operating income rose by 22% YoY

Price vs fundamentals

How does AEMD's price correlate with its fundamentals

Growth

What is Aethlon Medical's growth rate over time

Valuation

What is Aethlon Medical stock price valuation
P/E
N/A
P/B
0.16
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has surged by 88% YoY and by 80% QoQ
The P/B is 84% below the 5-year quarterly average of 1.0 and 68% below the last 4 quarters average of 0.5
The company's equity fell by 27% QoQ and by 4.6% YoY

Efficiency

How efficient is Aethlon Medical business performance
The ROE has grown by 38% YoY and by 37% from the previous quarter
The ROA has grown by 36% from the previous quarter and by 32% YoY
Aethlon Medical's ROIC has increased by 16% from the previous quarter but it has decreased by 14% YoY

Dividends

What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AEMD.

Financial health

How did Aethlon Medical financials performed over time
The quick ratio has contracted by 37% from the previous quarter but it has grown by 19% YoY
Aethlon Medical's total liabilities has decreased by 35% YoY but it has increased by 8% from the previous quarter
The company's debt is 93% lower than its equity
The company's debt fell by 48% YoY and by 19% QoQ
The debt to equity has declined by 46% year-on-year but it has increased by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.